Evidence profile
Ipamorelin
Ipamorelin study rows link each listed finding to its source, model or population, and endpoint.
Cited headline finding
The pharmacology study characterized ipamorelin as a selective growth-hormone secretagogue. ↗
Rat and swine pharmacologyRaun et al., European Journal of Endocrinology 1998Animal
Mechanism scope
How cited research characterizes Ipamorelin
Raun et al. characterized Ipamorelin as a selective growth-hormone secretagogue in rat and swine pharmacology.
Sources: Raun et al., European Journal of Endocrinology 1998 ↗
Open question
What the cited Ipamorelin sources do not resolve
The cited Ipamorelin pharmacology study does not answer outcomes beyond its rat and swine experimental systems.
Sources: Raun et al., European Journal of Endocrinology 1998 ↗
| Finding | Year | n | Model or population | Endpoint | Source | Evidence tier |
|---|---|---|---|---|---|---|
| The pharmacology study characterized ipamorelin as a selective growth-hormone secretagogue. | 1998 | Not stated | Rat and swine pharmacology | Growth-hormone release and hormone selectivity | Raun et al., European Journal of Endocrinology 1998 ↗ | Animal |
Regulatory status
Ipamorelin appears in Health Canada's peptide-drug advisory. ↗
Related source
Source notes
Reviewer: Ember Peptides source-verification editorial review · Review date: 2026-09-13